ติดตาม
John Bartlett
John Bartlett
Director of Transformative Pathology, Ontario Institute for Cancer Research
ยืนยันอีเมลแล้วที่ oicr.on.ca - หน้าแรก
ชื่อ
อ้างโดย
อ้างโดย
ปี
College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer
AC Wolff, ME Hammond, JN Schwartz, KL Hagerty, DC Allred, RJ Cote, ...
J clin oncol 25 (1), 118-145, 2007
62952007
Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice …
AC Wolff, MEH Hammond, DG Hicks, M Dowsett, LM McShane, ...
Journal of clinical oncology 31 (31), 3997-4013, 2013
57022013
Comprehensive molecular characterization of gastric adenocarcinoma
Cancer Genome Atlas Research Network
Nature 513 (7517), 202, 2014
56112014
Integrated genomic characterization of endometrial carcinoma
DA Levine, ...
Nature 497 (7447), 67-73, 2013
53472013
The immune landscape of cancer
V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ...
Immunity 48 (4), 812-830. e14, 2018
50462018
Comprehensive genomic characterization of squamous cell lung cancers
Cancer Genome Atlas Research Network
Nature 489 (7417), 519, 2012
38452012
Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline focused update
AC Wolff, MEH Hammond, KH Allison, BE Harvey, PB Mangu, ...
Archives of pathology & laboratory medicine 142 (11), 1364-1382, 2018
30402018
Genomic classification of cutaneous melanoma
R Akbani, KC Akdemir, B áArman Aksoy, M Albert, A Ally, SB Amin, ...
Cell 161 (7), 1681-1696, 2015
29392015
Comprehensive molecular characterization of urothelial bladder carcinoma
Cancer Genome Atlas Research Network
Nature 507 (7492), 315, 2014
27852014
Pan-cancer analysis of whole genomes
Nature 578 (7793), 82-93, 2020
2546*2020
Comprehensive molecular characterization of muscle-invasive bladder cancer
AG Robertson, J Kim, H Al-Ahmadie, J Bellmunt, G Guo, AD Cherniack, ...
Cell 171 (3), 540-556. e25, 2017
25032017
Comprehensive characterization of cancer driver genes and mutations
MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ...
Cell 173 (2), 371-385. e18, 2018
24392018
Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group
M Dowsett, TO Nielsen, R A’Hern, J Bartlett, RC Coombes, J Cuzick, ...
Journal of the National cancer Institute 103 (22), 1656-1664, 2011
21482011
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials
B Asselain, W Barlow, J Bartlett, J Bergh, E Bergsten-Nordström, J Bliss, ...
The Lancet Oncology 19 (1), 27-39, 2018
10362018
A short history of the polymerase chain reaction
JMS Bartlett, D Stirling
PCR protocols, 3-6, 2003
10162003
Association between CD8+ T-cell infiltration and breast cancer survival in 12 439 patients
HR Ali, E Provenzano, SJ Dawson, FM Blows, B Liu, M Shah, HM Earl, ...
Annals of Oncology 25 (8), 1536-1543, 2014
8762014
Expression of the HER1–4 family of receptor tyrosine kinases in breast cancer
CJ Witton, JR Reeves, JJ Going, TG Cooke, JMS Bartlett
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2003
7592003
An international Ki67 reproducibility study
MYC Polley, SCY Leung, LM McShane, D Gao, JC Hugh, ...
Journal of the National Cancer Institute 105 (24), 1897-1906, 2013
6972013
Integrated genomic characterization of pancreatic ductal adenocarcinoma
BJ Raphael, RH Hruban, AJ Aguirre, RA Moffitt, JJ Yeh, C Stewart, ...
Cancer cell 32 (2), 185-203. e13, 2017
6872017
Guidelines for human epidermal growth factor receptor 2 testing: biologic and methodologic considerations
G Sauter, J Lee, JMS Bartlett, DJ Slamon, MF Press
Journal of Clinical Oncology 27 (8), 1323-1333, 2009
6672009
ระบบไม่สามารถดำเนินการได้ในขณะนี้ โปรดลองใหม่อีกครั้งในภายหลัง
บทความ 1–20